Clinical Trials · NCT02527200
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 56
- Start date
- Nov 2015
- Locations
- 32 sites, 8 countries
- Primary endpoint
- Change in Body Mass Index (BMI) Standard Deviation Score (SDS) From Baseline to 16 Weeks